Baxter International (BAX) Accumulated Expenses (2009 - 2026)

Baxter International (BAX) has 17 years of Accumulated Expenses data on file, last reported at $1.8 billion in Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 4.9% year-over-year to $1.8 billion in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 4.9% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 5.75% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $1.8 billion, down from $2.0 billion in the prior quarter.
• Over the last five years, Accumulated Expenses for BAX reached as high as $2.5 billion in Q3 2023 and fell as low as $1.8 billion in Q1 2026.
• Historically, Accumulated Expenses has averaged $2.1 billion across 5 years, with a median of $2.2 billion in 2022.
• Across the five-year window, Accumulated Expenses rose 28.51% in 2022 and tumbled 30.15% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $2.2 billion in 2022, then decreased by 11.75% to $1.9 billion in 2023, then retreated by 2.82% to $1.9 billion in 2024, then rose by 5.75% to $2.0 billion in 2025, then declined by 10.32% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $1.8 billion in Q1 2026, $2.0 billion in Q4 2025, and $2.1 billion in Q3 2025.